Cationic nanoemulsions with prolonged retention time as promising carriers for ophthalmic delivery of tacrolimus
- PMID: 31958581
- DOI: 10.1016/j.ejps.2020.105229
Cationic nanoemulsions with prolonged retention time as promising carriers for ophthalmic delivery of tacrolimus
Abstract
Tacrolimus, also known as FK506, is a first-line drug for the topical treatment of immune-mediated inflammatory anterior ocular diseases (IIAODs). However, due to its limited water solubility, hydrophobic nature and relatively high molecular weight, topical application of FK506 features poor bioavailability. Numbers of formulations have been attempted to enhance the erratic bioavailability of FK506 through various techniques. But until now, none of them could satisfy the clinical needs completely. Here, a novel formulation of FK506, FK506-loaded cationic nanoemulsions (FK506 CNE), was developed to prolong the precorneal residence time of FK506, thereby enhancing the bioavailability of FK506 for IIAODs therapy. FK506 CNE was prepared by high-pressure homogenization, and its composition was screened and optimized by single-factor experiments. The FK506 CNE showed spherical morphology with a mean diameter of 178.8 ± 2.7 nm and a zeta potential of +25.6 ± 0.6 mV. Results from in vivo gamma scintigraphy studies proved that the precorneal residence time of FK506 CNE was significantly increased, compared with FK506-loaded neutral nanoemulsions (FK506 NE) and saline. The data of aqueous humor pharmacokinetic study in rabbits showed that the relative bioavailability of FK506 CNE was 1.68-fold and 1.77-fold of FK506 NE and the marketed FK506 eye drops (Talymus®), respectively. Finally, hematoxylin and eosin staining images and in vitro cytotoxicity data confirmed the safety of the FK506 CNE. Taking all these into consideration, we propose that FK506 CNE is a promising topical ophthalmic nanoformulation for the management of IIAODs.
Copyright © 2020 Elsevier B.V. All rights reserved.
Similar articles
-
Hyaluronic acid-coated niosomes facilitate tacrolimus ocular delivery: Mucoadhesion, precorneal retention, aqueous humor pharmacokinetics, and transcorneal permeability.Colloids Surf B Biointerfaces. 2016 May 1;141:28-35. doi: 10.1016/j.colsurfb.2016.01.014. Epub 2016 Jan 11. Colloids Surf B Biointerfaces. 2016. PMID: 26820107
-
A novel FK506 loaded nanomicelles consisting of amino-terminated poly(ethylene glycol)-block-poly(D,L)-lactic acid and hydroxypropyl methylcellulose for ocular drug delivery.Int J Pharm. 2019 May 1;562:1-10. doi: 10.1016/j.ijpharm.2019.03.022. Epub 2019 Mar 13. Int J Pharm. 2019. PMID: 30878586
-
Preparation of 0.05% FK506 suspension eyedrops and its pharmacokinetics after topical ocular administration.J Ocul Pharmacol Ther. 2009 Aug;25(4):345-50. doi: 10.1089/jop.2008.0125. J Ocul Pharmacol Ther. 2009. PMID: 19492954
-
Benefits of cetalkonium chloride cationic oil-in-water nanoemulsions for topical ophthalmic drug delivery.J Pharm Pharmacol. 2014 Apr;66(4):531-41. doi: 10.1111/jphp.12075. J Pharm Pharmacol. 2014. PMID: 24001405 Free PMC article. Review.
-
Tacrolimus in the treatment of ocular diseases.BioDrugs. 2011 Apr 1;25(2):89-103. doi: 10.2165/11587010-000000000-00000. BioDrugs. 2011. PMID: 21443273 Review.
Cited by
-
Development and Characterization of Nanoemulsions for Ophthalmic Applications: Role of Cationic Surfactants.Materials (Basel). 2021 Dec 8;14(24):7541. doi: 10.3390/ma14247541. Materials (Basel). 2021. PMID: 34947136 Free PMC article. Review.
-
Nanoemulsions as Ophthalmic Drug Delivery Systems.Turk J Pharm Sci. 2021 Oct 28;18(5):652-664. doi: 10.4274/tjps.galenos.2020.59319. Turk J Pharm Sci. 2021. PMID: 34708428 Free PMC article.
-
Topical tacrolimus nanocapsules eye drops for therapeutic effect enhancement in both anterior and posterior ocular inflammation models.J Control Release. 2021 May 10;333:283-297. doi: 10.1016/j.jconrel.2021.03.035. Epub 2021 Mar 30. J Control Release. 2021. PMID: 33798665 Free PMC article.
-
Lipid-Based Nanoparticulate Systems for the Ocular Delivery of Bioactives with Anti-Inflammatory Properties.Int J Mol Sci. 2022 Oct 11;23(20):12102. doi: 10.3390/ijms232012102. Int J Mol Sci. 2022. PMID: 36292951 Free PMC article. Review.
-
The Effect of High-Pressure Homogenization Conditions on the Physicochemical Properties and Stability of Designed Fluconazole-Loaded Ocular Nanoemulsions.Pharmaceutics. 2023 Dec 20;16(1):11. doi: 10.3390/pharmaceutics16010011. Pharmaceutics. 2023. PMID: 38276489 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources